| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 38821-53-3 | 頭孢拉定; (6R,7R)-7-[(R)-2-氨基-2-(1,4-環(huán)己二烯基)乙酰氨基]-3-甲基-8-氧代-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛- | Cefradine; Cephradine; (6R-(6alpha,7))-((Amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ![]() | C16H19N3O4S | 詳情 | 供應(yīng)商 |
| 76610-84-9 | 頭孢拉宗; (6R,7S)-7-((2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰氨基)-3-羥基丁酰氨基)-7-甲氧基-3-(((1-甲 | Cefbuperazone | ![]() | C22H29N9O9S2 | 詳情 | 供應(yīng)商 |
| 76648-01-6 | 頭孢拉宗鈉; (6R,7S)-7-[[(2R,3S)-2-[(4-乙基-2,3-二氧代哌嗪-1-甲酰)氨基]-3-羥基丁酰]氨基]-7-甲氧基-3-[( | Cefbuperazone sodium; Sodium (6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-ca | ![]() | C22H28N9NaO9S2 | 詳情 | 供應(yīng)商 |
| 58456-86-3 | 頭孢拉啶 | CEPHRADINE (200 MG); CEPHRADINE (200 MG); (6R,7R)-7-[[2-amino-2-(1-cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8 -oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate; Cephradine dihydrate; SQ-22022 | 無(wú) | C16H23N3O6S | 詳情 | 供應(yīng)商 |
| 79276-23-6 | 頭孢拉宗側(cè)鏈; D-α-(4-乙基-2,3-二氧哌嗪甲酰胺基)-β-(S)-叔丁氧基丁酸 | D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid; D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid; D-α-(4-乙基-2,3-二氧-哌嗪甲酰胺基)-β-(S)羥基丁酸; D-Threonine, O-(1,1-diMethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-; O-(1,1-Dimethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonine | 無(wú) | C15H25N3O6 | 詳情 | 供應(yīng)商 |